It is made up of an international and multidisciplinary group of healthcare professionals in the fields of sarcopenia, cachexia and muscle wasting.
[11] As of 2018, the society had 150 members.Journal of Cachexia, Sarcopenia and Muscle - Wiley Online Library The purpose and objectives of the Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) are to: The SCWD is a non-profit scientific organization (501 c3)[14] registered in the United States of America and Switzerland.
[16]The Board consists of: Stefan D. Anker (President[17]) – Berlin, Germany Josep M. Argiles – Barcelona, Spain Vickie E. Baracos – Edmonton, Canada Andrew J. S. Coats (Treasurer) – Norwich, UKWolfram Doehner – Berlin, Germany William J. Evans[18] – Duke University, US Luigi Ferrucci[19] – Baltimore, US David J.
Glass – Boston, USAkio Inui – Kobe, JapanAminah Jatoi – Rochester, USKamyar Kalantar-Zadeh – Los Angeles, USJohn E. Morley (vice-president) – St. Louis, USFilippo Rossi-Fanelli – Rome, ItalyFlorian Strasser – St. Gallen, Switzerland Stephan von Haehling – Göttingen, Germany Prof Ken Fearon was a board member until he died in September 2016.
The invited experts are well-recognized academic leaders in geriatrics, oncology, cardiology, pulmonology and regulatory issues.
These consensus projects aimed to facilitate the future design and performance of clinical trials in the fields of cachexia and sarcopenia[44] They also generated recommendations for nutritional management.
[49] Two daughter journals also exist: JCSM—Clinical Reports Archived 3 February 2019 at the Wayback Machine started in July 2016 and JCSM—Rapid Communications.
Two common but distinct conditions characterized by a loss of skeletal muscle mass are sarcopenia and cachexia.
It has been known for millennia that muscle and fat wasting leads to poor outcomes, including deaths in chronic disease states.
[53] Cachexia and sarcopenia are both characterized by an important muscle dysfunction and weakness[54] that lead to increased morbidity and mortality.